Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
批准号:
10631700
负责人:
Jonathan A Cooper
金额:
$21.52万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2023-08-31
关键词:
Adaptor Signaling ProteinAdhesionsAreaBCAR1 geneBCAR3 geneBindingBreast Cancer CellCISH geneCancer BiologyCell ProliferationCellsCellular biologyComplexCullin 5 ProteinEpithelial CellsFocal AdhesionsFundingGenesGoalsImageImmunityLearningLigaseLinkMalignant NeoplasmsMethodsMolecularMutation AnalysisNormal CellOncogenicPathway interactionsPhenotypePhosphorylationPhosphotyrosinePost-Translational Protein ProcessingProceduresProtein DephosphorylationProtein Tyrosine KinaseProtein Tyrosine PhosphataseProteinsProteomicsPublishingReagentRegulationResearchRoleSignal PathwaySignal TransductionSignaling ProteinSiteSystemTestingTyrosineTyrosine PhosphorylationUbiquitinbreast malignanciescancer cellcancer survivalcell motilitycell transformationinnovationmalignant breast neoplasmmammarymigrationmulticatalytic endopeptidase complexnovel strategiesoptogeneticsprognostic indicatorscaffoldubiquitin-protein ligasewound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Protein tyrosine kinases (PTKs) phosphorylate tyrosine in proteins involved in cell signaling pathways that
stimulate cell migration, proliferation and oncogenic transformation. Phosphotyrosine (pY) proteins may be
inactivated by dephosphorylation or by proteasomal degradation following ubiquitylation by pY-specific
ubiquitin E3 ligases. We are focusing on the multi-subunit Cullin 5-RING ligase (CRL5), which interacts with pY
proteins through suppressors of cytokine signaling (SOCS) adaptor proteins. Our past studies have shown that
various CRL5-SOCS complexes are critical in normal epithelial cells to repress an oncogenic PTK, Src. When
we inhibit expression of Cullin 5 or specific SOCS genes, Src is activated and cell migration, proliferation and
transformation are stimulated. Increased Src activity is necessary but not sufficient for the migration and
proliferation of Cullin 5-deficient cells, suggesting that CRL5 has additional substrates. Our past studies have
identified two such substrates that are critical for cell migration. Here we propose to extend these studies, to
understand how CRL5-SOCS regulates epithelial cell migration. Our scientific premise is that the identification
of key CRL5-SOCS substrates and functions in migration is critical for understanding normal and transformed
cell biology.
During the last funding period, we used innovative live imaging, optogenetics and mutational analysis to
uncover the molecular mechanism by which CRL5-SOCS6 regulates the signaling scaffold, Cas (Crk-
associated substrate), within focal adhesion sites at the leading edge of migrating epithelial cells. We also used
quantitative proteomics to identify other CRL5 substrates and test their roles in cell migration. Specifically, we
identified BCAR3 (breast cancer anti-estrogen resistance 3) as a second CRL5-SOCS6 substrate that
regulates cell migration. Finally, we found that SOCS2, like SOCS6, localizes to focal adhesion sites and
regulates cytoskeletal dynamics.
We propose three broad aims to extend these observations and understand the molecular mechanisms. First,
we will understand the importance of BCAR3 phosphorylation in BCAR3 stability and focal adhesion dynamics.
Second, BCAR3 binds and cooperates with Cas: each protein stabilizes the other from degradation. We will
understand the mechanism and importance of BCAR3-Cas mutual stabilization. Third, we will determine the
mechanism by which SOCS2 regulates focal adhesion dynamics. Together, these aims will extend our
understanding of how protein-tyrosine phosphorylation and ubiquitylation cooperate to regulate cell migration.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.neo.2018.01.006
发表时间:
2018-03
期刊:
Neoplasia (New York, N.Y.)
影响因子:
--
作者:
[Li Q, Ingram L, Kim S, Beharry Z, Cooper JA, Cai H]
通讯作者:
Cai H
SOCS2 Binds to and Regulates EphA2 through Multiple Mechanisms.
SOCS2 通过多种机制结合并调节 EphA2。
DOI:
10.1038/s41598-017-11040-3
发表时间:
2017
期刊:
Scientific reports
影响因子:
4.6
作者:
[Pilling,Carissa, Cooper,JonathanA]
通讯作者:
Cooper,JonathanA
Mechanisms of Purkinje cell migration
-
批准号:8804825
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2014
-
负责人:Jonathan A Cooper
-
依托单位:
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
-
批准号:10064153
-
项目类别:
-
资助金额:$36.96万
-
财政年份:2014
-
负责人:Jonathan A Cooper
-
依托单位:
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
-
批准号:8901233
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2014
-
负责人:Jonathan A Cooper
-
依托单位:
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
-
批准号:10295778
-
项目类别:
-
资助金额:$15.44万
-
财政年份:2014
-
负责人:Jonathan A Cooper
-
依托单位:
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
-
批准号:10668575
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2014
-
负责人:Jonathan A Cooper
-
依托单位:
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
-
批准号:9275485
-
项目类别:
-
资助金额:$33.7万
-
财政年份:2014
-
负责人:Jonathan A Cooper
-
依托单位:
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
-
批准号:8760249
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2014
-
负责人:Jonathan A Cooper
-
依托单位:
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin
-
批准号:9067447
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2014
-
负责人:Jonathan A Cooper
-
依托单位:
Receptor Tyrosine Kinases: Biology and Cancer
-
批准号:7916135
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2010
-
负责人:Jonathan A Cooper
-
依托单位:
Normal and Cancer Stem Cells of the Mammary Gland
-
批准号:8300983
-
项目类别:
-
资助金额:$48.36万
-
财政年份:2009
-
负责人:Jonathan A Cooper
-
依托单位:
Chromosome Metabolism and Cancer
-
批准号:7812825
-
项目类别:
-
资助金额:$21.44万
-
财政年份:2009
-
负责人:Jonathan A Cooper
-
依托单位:
In vivo functions of possible tumor suppressor Dab2
-
批准号:6893476
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2003
-
负责人:Jonathan A Cooper
-
依托单位:
In vivo functions of possible tumor suppressor Dab2
-
批准号:6752904
-
项目类别:
-
资助金额:$47.56万
-
财政年份:2003
-
负责人:Jonathan A Cooper
-
依托单位:
In vivo functions of possible tumor suppressor Dab2
-
批准号:7080478
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2003
-
负责人:Jonathan A Cooper
-
依托单位:
In vivo functions of possible tumor suppressor Dab2
-
批准号:6598401
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2003
-
负责人:Jonathan A Cooper
-
依托单位:
Functions and mechanisms of the endocytic adaptor Dab2
-
批准号:7627937
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2003
-
负责人:Jonathan A Cooper
-
依托单位:
In vivo functions of possible tumor suppressor Dab2
-
批准号:6896811
-
项目类别:
-
资助金额:$47.84万
-
财政年份:2003
-
负责人:Jonathan A Cooper
-
依托单位:
Functions and mechanisms of the endocytic adaptor Dab2
-
批准号:8072191
-
项目类别:
-
资助金额:$41.05万
-
财政年份:2003
-
负责人:Jonathan A Cooper
-
依托单位:
Functions and mechanisms of the endocytic adaptor Dab2
-
批准号:7460959
-
项目类别:
-
资助金额:$41.89万
-
财政年份:2003
-
负责人:Jonathan A Cooper
-
依托单位:
Research Program: Cancer Basic Biology
-
批准号:10636804
-
项目类别:
-
资助金额:$7.62万
-
财政年份:1997
-
负责人:Jonathan A Cooper
-
依托单位:
海外基金